Krystal Biotech Inc at William Blair Growth Stock Conference Transcript
Good morning. My name is Tim Lugo. For those of you I haven't met, I'm the head of biotech research here at William Blair.
And before we get too deeply into the discussion with Krish Krishnan, CEO of Krystal Biotech, as well as Meg Dodge -- thank you for joining us -- Head of Investor Relations at Krystal Biotech. And before we get too deep into it, you must check williamblair.com for all relevant disclosures.
I just want to note, before Krish's presentation, it's a great time for an investor to be looking at Krystal Biotech. Recent FDA approval should bring the first topical gene therapy to a very needy population, the DEB patient. It's a horrible disease.
It's great that Krish and the team at Krystal has developed this therapy for what is a very needy population. They're going to be launching their drug currently, I believe. And Krish will tell us all about how he's bringing this to change patients' lives over the next year.
So with that, I'd love to welcome Krish from Krystal Biotech.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
